HCW Biologics Shares Fall Amid Delisting Notice From Nasdaq

MT NewswiresDec 24, 2024 00:27

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

GlobeNewswireDec 23, 2024 21:10

HCW Biologics Expands With New Financial Agreements

TipRanksNov 21, 2024 05:56

Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket

BenzingaNov 19, 2024 19:30

HCW Biologics to Raise $6.9 Million in Gross Proceeds From Direct Offering, Private Placement; Shares Extend Gains Premarket

MT NewswiresNov 19, 2024 19:28

Stock alert | HCW Biotech surged more than 20% pre-market, signing a global exclusive licensing agreement with Tongweiyuan Biotech.

Futu news reported on November 19 that the biopharmaceutical company $HCW Biologics (HCWB.US)$ rose over 40% in pre-market trading today. As of the time of writing, the stock was up 20.97% at $1.50, with a pre-market trading volume of $2.932 million. Notably, in the previous trading session, HCW Biologics’ stock price surged 320.91%, with a volume of 0.513 billion. Market data source: futubull >> On the news side, HCW Biologics announced yesterday that it had signed a global exclusive licensing agreement with Weiyuan Biotech, and the core of this agreement is a technology developed by HCW Biologics using its advanced...

Futu NewsNov 19, 2024 18:06